Empower Pharmacy: 503A + 503B compounder profile

Empower is one of the larger names in US compounding, operating as both a patient-specific 503A pharmacy and an FDA-registered 503B outsourcing facility. That dual status is the thing to understand first: the same company can prepare a one-off patient prescription (503A) and manufacture larger office-use batches under CGMP (503B).

Facility & accreditation

Empower appears on the FDA’s Registered Outsourcing Facilities (503B) list as “Empower Pharma, Houston, TX” (initial registration July 16, 2016), with a related “Empower Clinic Services” entity registered in East Windsor, NJ [1]. The company describes itself as a 503A compounding pharmacy and 503B outsourcing facility and says it is licensed to ship nationwide, including Puerto Rico [2].

We independently confirmed Empower’s PCAB accreditation in ACHC’s own accredited-organization directory (ACHC administers PCAB): “Empower Clinic Services, LLC / Empower Pharmacy,” Houston, TX, holds PCAB Compounding Pharmacy accreditation valid January 10, 2026 – January 9, 2029, covering non-sterile (USP <795>), sterile (USP <797>), and hazardous-drug (USP <800>) compounding [3]. The site also shows a LegitScript certification, which we did not independently verify (LegitScript’s per-domain checker is access-gated).

What they compound

Relevant to peptide and metabolic care: compounded GLP-1s (semaglutide, tirzepatide), a dedicated peptide line (including sermorelin and GHK-Cu), testosterone/HRT, HCG, NAD+, and enclomiphene [2].

Regulatory record

Per the FDA 503B list, Empower’s Houston facility was last inspected on November 14, 2025, which resulted in a Form 483; FDA shows the action status as “Open,” with no recall and no warning letter listed as of the list’s May 2026 update [1]. A Form 483 records an investigator’s inspection observations — it is not, by itself, a final finding of violation. Status can change; this reflects the FDA list at our review date.

The read

A high-volume, dual-status operator with one of the broadest GLP-1/peptide/HRT catalogs in the set and genuine 503B registration — which means more federal oversight and paper trail than a state-only 503A. The open 483 is worth watching but is not unusual for a facility of this scale.

References

1. FDA — Registered Outsourcing Facilities (503B) list. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities (accessed 2026-07-01)
2. Empower Pharmacy — official site. https://www.empowerpharmacy.com/ (accessed 2026-07-01)
3. ACHC / PCAB accredited-organization directory. https://organization.achc.org/ (accessed 2026-07-01)